Alligator Bioscience AB
STO:ATORX

Watchlist Manager
Alligator Bioscience AB Logo
Alligator Bioscience AB
STO:ATORX
Watchlist
Price: 3.8305 SEK -1.78% Market Closed
Market Cap: 118.3m SEK

Wall Street
Price Targets

ATORX Price Targets Summary
Alligator Bioscience AB

Wall Street analysts forecast ATORX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATORX is 18.36 SEK with a low forecast of 18.18 SEK and a high forecast of 18.9 SEK.

Lowest
Price Target
18.18 SEK
375% Upside
Average
Price Target
18.36 SEK
379% Upside
Highest
Price Target
18.9 SEK
393% Upside
Alligator Bioscience AB Competitors:
Price Targets
CSL
CSL Ltd
33% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
40% Upside
2171
CARsgen Therapeutics Holdings Ltd
48% Downside
LEGN
Legend Biotech Corp
124% Upside
INCY
Incyte Corp
8% Upside
MSB
Mesoblast Ltd
60% Upside
9926
Akeso Inc
19% Upside
MDGL
Madrigal Pharmaceuticals Inc
54% Upside

Revenue
Forecast

Revenue Estimate
Alligator Bioscience AB

For the last 8 years the compound annual growth rate for Alligator Bioscience AB's revenue is 0%. The projected CAGR for the next 2 years is 17%.

0%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Alligator Bioscience AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Alligator Bioscience AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-94%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATORX's stock price target?
Price Target
18.36 SEK

According to Wall Street analysts, the average 1-year price target for ATORX is 18.36 SEK with a low forecast of 18.18 SEK and a high forecast of 18.9 SEK.

What is Alligator Bioscience AB's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Alligator Bioscience AB's revenue is 0%. The projected CAGR for the next 2 years is 17%.

Back to Top